Abstract:The aim of this study was to develop and test an optimal vaccination strategy against bovine viral diarrhea virus (BVDV) based on the E2 glycoprotein of the BJ1305 strain. To achieve higher E2-specific antibody titers and to broaden the cellular immune response, a plasmid encoding the E2 protein (pcDNA3.1-E2) was constructed and a purified recombinant E2 protein was generated. The E2 protein was emulsified in the adjuvant ISA 61 VG prior to administration. We immunized mice three times with pcDNA3.1-E2 or the recombinant E2 protein or primed twice with pcDNA3.1-E2 and boosted once with the E2 protein. To evaluate the protection against BVDV conferred by the vaccines, the mice were challenged with BVDV strain Oregon C24V after the third immunization. Although all immunized mice developed humoral and cellular immune responses, the E2-specific antibody titers in the DNA prime-protein boost group were significantly higher than those elicited by either the DNA or the protein vaccine. In addition, vaccination with the E2 DNA vaccine induced higher percentages of CD4(+)IFN-gamma(+) T cells and CD8(+)IFN-gamma(+) T cells among total CD3(+) T cells than the other regimens. The predominant antibody subclass in the vaccinated mice was IgG1. Serum tumor necrosis factor alpha (TNE-alpha) levels in the DNA prime-protein boost group were significantly higher after the third immunization than in the other groups. Moreover, the mice treated with the DNA prime-protein boost vaccination regimen acquired protection against BVDV challenge, as shown by a significant reduction of viremia, only minor pathological changes, and a lower viral antigen burden than in the control and solo vaccinated mice. These results demonstrate the potential advantage of a DNA prime-protein boost vaccination approach over a solo vaccination for the prevention of BVDV. The ability of this vaccine strategy to control and eradicate BVD in herds warrants further investigation. (C) 2018 Elsevier Ltd. All rights reserved.

Combined immunity of DNA vector and recombinant vaccinia virus expressing Gag proteins of equine infectious anemia virus

Combination Immunization with EIAV Env Protein Expressed by Recombinant Baculovirus and Recombinant Vaccinia Virus Containing Env Gene

A Pilot Study Comparing the Development of EIAV Env-Specific Antibodies Induced by DNA/Recombinant Vaccinia-Vectored Vaccines and an Attenuated Chinese EIAV Vaccine

Induction of Protective Immune Response in Chickens Immunized with Plasmid DNA Encoding Antigens of Infectious Bursal Disease Virus

[Expression and Immunogenicity of Equine Infectious Anemia Virus Membrane Protein GP90].

Enhanced Immune Responses to E2 Protein and DNA Formulated with ISA 61 VG Administered As a DNA Prime–protein Boost Regimen Against Bovine Viral Diarrhea Virus

A Pilot Study on an Attenuated Chinese EIAV Vaccine Inducing Broadly Neutralizing Antibodies

Study on the Infectivity of Vaccinia Virus in Equine Cells

CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.

biao da eiav gag dan bai de dna zai ti yu zhong zu dou miao bing du lian he mian yi xiao guo de guan cha

[Induction of EIAV-specific Cellular Immune Response by Attenuated EIAV Vaccine].

Construction and Immunogenicity of Recombinant Expression Vectors of Western Equine Encephalomyelitis Virus

Enhancement of Humoral and Cellular Immunity in Mice Against Japanese Encephalitis Virus Using a DNA Prime–protein Boost Vaccine Strategy

An Attenuated EIAV Vaccine Strain Induces Significantly Different Immune Responses from Its Pathogenic Parental Strain Although with Similar in Vivo Replication Pattern

Potent T Cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine.

Research on Construction of DNA Vaccine of Recombinant Porcine Parvovirus Virus Coexpressing E10 Protein of Japanese Encephalitis Virus Fused with poIFN-γ gene and Its Immunogenicity in Mice

Eliciting specific humoral immunity from a plasmid DNA encoding infectious bursal disease virus polyprotein gene fused with avian influenza virus hemagglutinin gene

The recombinant EHV-1 vector producing CDV hemagglutinin as potential vaccine against canine distemper

Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses

Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses Upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins